Boothbay Fund Management’s Gossamer Bio GOSS Stock Holding History

Boothbay Fund Management’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,823	Closed	-$47.9K	–	2396
2026 Q1	$47.9K	Buy	1,823 +104	+6%	+$13.1K	﹤0.01%	1929
2025 Q4	$426K	Buy	+1,719	New	+$392K	0.01%	1228
2022 Q4	–	Sell	-1,003	Closed	-$961K	–	2164
2022 Q3	$961K	Buy	1,003 +464	+86%	+$461K	0.02%	899
2022 Q2	$361K	Buy	+539	New	+$334K	0.01%	1349
2022 Q1	–	Sell	-251	Closed	-$227K	–	2369
2021 Q4	$227K	Buy	251 +20	+9%	+$19K	0.01%	1423
2021 Q3	$233K	Buy	+231	New	+$170K	0.01%	1478
2021 Q2	–	Sell	-4	Closed	-$283K	–	1952
2021 Q1	$283K	Sell	4 -1	-20%	-$807	0.01%	1220
2020 Q4	$385K	Buy	+5	New	+$3.94K	0.01%	852
2019 Q4	–	Sell	-12	Closed	-$1.64M	–	892
2019 Q3	$1.64M	Buy	+12	New	+$19.1K	0.15%	186

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Boothbay Fund Management's GOSS Position: Q1 2024 in Review

Boothbay Fund Management sold out of Gossamer Bio (GOSS) in Q1 2024, closing a stake of 729 shares — an estimated $53.2K sold.

Boothbay Fund Management first reported a position in GOSS in Q1 2019 and held it in 12 quarters. The position peaked at $1.69M in Q3 2021. 108 funds tracked by Wall St. Rank hold GOSS as of Q1 2024.

Boothbay Fund Management reported no remaining Gossamer Bio position as of Q1 2024 after selling out during the quarter.
Boothbay Fund Management sold 729 Gossamer Bio shares in Q1 2024, an estimated $53.2K.
Boothbay Fund Management first reported a position in Gossamer Bio in Q1 2019 and held it in 12 quarters.
Boothbay Fund Management's Gossamer Bio position peaked at $1.69M in Q3 2021.
108 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.